医药产品商标的负效用及矫正  

Disutility and Correction on the Role of a Trademark in Pharmaceutical Industry

作　　者：王优飞 胡允银[2] 张蒙娟 WANG You-fei;HU Yun-yin;ZHANG Meng-juan(Zhejiang You fei law Firm,Zhejiang Taizhou 318000,China;Trade and economic management college,Taizhou University, Zhejiang Taizhou 318000,China;law school,Chongqing University, Chongqing 400030,China)

机构地区：[1]浙江优飞律师事务所,浙江台州318000 [2]台州学院经贸管理学院,浙江台州318000 [3]重庆大学法学院,重庆400030

出　　处：《科技与法律》2018年第2期64-69,共6页Science Technology and Law

摘　　要：通常认为专利法在抑制患者获得更便宜的仿制药物上扮演着重要角色。然而,药品商标实际上也在发挥同样重要作用。医药产品商标和外观造成仿制药和品牌药人工产品差异化,从而导致患者非理性消费甚至部分贫困患者因无钱医治而死亡。如果让药品制造商使用药品通用名称和企业名称相结合的标记方法来替代当前商标,这种标记制度会将品牌药和仿制药的生物等效性阐释清楚,同时也不影响患者识别药物的来源和药物制造商商誉的培育。The patent law has often been thought to play an important role in the inhibition of patients getting cheaper generic drugs. However, pharmaceutical trademarks can play the same role. Pharmaceutical trademarks and appearance design make differentiation between generics and brand-drugs, which led to irrational consumption and even some poor patients death because there was no money to heal. If the combination tag of generic names and corporate name is used to replace the current logo, not only this sign system can clearly indicates the drugs bioequivalence between generics and brands, but also it does not affect the patients to identify the source of the drug and prevent the manufactures to foster goodwill.

关 键 词：品牌药 仿制药 生物等效性 商标 

分 类 号：D923[政治法律—民商法学]